Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis.

ABSTRACT:

Objective

We estimated coronavirus disease 2019 (COVID-19) vaccination rates in the North American Research Committee on Multiple Sclerosis (NARCOMS) population and investigated reasons for vaccine hesitancy.

Methods

In Spring 2021, we surveyed the NARCOMS participants about COVID-19 vaccinations. Participants reported whether they had received any COVID-19 vaccination; if not, they reported why not. They also reported whether they had received influenza vaccination. Using multivariable logistic regression, we assessed participant characteristics associated with uptake of COVID-19 and influenza vaccines.

Results

Of 4955 eligible respondents, 3998 (80.7%) were females with a mean (SD) age of 64.0 (9.7) years. Overall, 4165 (84.1%) reported that they had received a COVI

SUBMITTER: Marrie RA 

PROVIDER: S-EPMC9131385 | biostudies-literature | 2022 Apr-Jun

REPOSITORIES: biostudies-literature